Cozadd Bruce C

DirectorJazz Pharmaceuticals plc (JAZZ) · full profile →Form 4 · filed Sep 2, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$1.5M
Net Open-Market Flow
-$1.5M
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 1, 2026Sell(S)6K$250.13$1.5M352K
Aug 31, 2026Tax withholding(F)10$244.06$2K359K
Aug 31, 2026Tax withholding(F)1K$241.39$292K358K

Transaction Codes

S
Open-market sale
F
Shares withheld for taxes

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193210-26-000025) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

Build

Ask your agent about JAZZ insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0001193210-26-000025"
Ask your agent
Use Arkolith to summarize insider buying and selling at Jazz Pharmaceuticals plc
over the last 90 days and cite the filings.